Department of Medicine II, University of Freiburg, Freiburg, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany.
Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
J Hepatol. 2014 Jan;60(1):22-9. doi: 10.1016/j.jhep.2013.08.009. Epub 2013 Aug 23.
BACKGROUND & AIMS: HLA-B27 is associated with spontaneous HCV genotype 1 clearance. HLA-B27-restricted CD8+ T cells target three NS5B epitopes. Two of these epitopes are dominantly targeted in the majority of HLA-B27+ patients. In chronic infection, viral escape occurs consistently in these two epitopes. The third epitope (NS5B2820) was dominantly targeted in an acutely infected patient. This was in contrast, however, to the lack of recognition and viral escape in the large majority of HLA-B27+ patients. Here, we set out to determine the host factors contributing to selective targeting of this epitope.
Four-digit HLA class I typing and viral sequence analyses were performed in 78 HLA-B27+ patients with chronic HCV genotype 1 infection. CD8+ T cell analyses were performed in a subset of patients. In addition, HLA/peptide affinity was compared for HLA-B27:02 and 05.
The NS5B2820 epitope is only restricted by the HLA-B27 subtype HLA-B27:02 (that is frequent in Mediterranean populations), but not by the prototype HLA-B27 subtype B27:05. Indeed, the epitope is very dominant in HLA-B27:02+ patients and is associated with viral escape mutations at the anchor position for HLA-binding in 12 out of 13 HLA-B27:02+ chronically infected patients.
The NS5B2820 epitope is immunodominant in the context of HLA-B27:02, but is not restricted by other HLA-B27 subtypes. This finding suggests an important role of HLA subtypes in the restriction of HCV-specific CD8+ responses. With minor HLA subtypes covering up to 39% of specific populations, these findings may have important implications for the selection of epitopes for global vaccines.
HLA-B27 与自发性 HCV 基因型 1 清除有关。HLA-B27 限制性 CD8+ T 细胞靶向三个 NS5B 表位。其中两个表位在大多数 HLA-B27+患者中被优势靶向。在慢性感染中,这些两个表位持续发生病毒逃逸。第三个表位(NS5B2820)在急性感染患者中被优势靶向。然而,与大多数 HLA-B27+患者缺乏识别和病毒逃逸形成对比。在这里,我们旨在确定导致该表位选择性靶向的宿主因素。
对 78 例慢性 HCV 基因型 1 感染的 HLA-B27+患者进行了四位数字 HLA Ⅰ类分型和病毒序列分析。在一部分患者中进行了 CD8+ T 细胞分析。此外,比较了 HLA-B27:02 和 05 的 HLA/肽亲和力。
NS5B2820 表位仅由 HLA-B27 亚型 HLA-B27:02 限制(该亚型在地中海人群中常见),而不由原型 HLA-B27 亚型 B27:05 限制。事实上,该表位在 HLA-B27:02+患者中非常占优势,并且与 13 例 HLA-B27:02+慢性感染患者中的 12 例 HLA 结合的锚定位的病毒逃逸突变相关。
在 HLA-B27:02 的背景下,NS5B2820 表位是免疫优势表位,但不受其他 HLA-B27 亚型限制。这一发现表明 HLA 亚型在 HCV 特异性 CD8+反应的限制中起重要作用。由于次要 HLA 亚型覆盖了高达 39%的特定人群,这些发现可能对全球疫苗中表位的选择具有重要意义。